Accidental device removal is a significant patient safety challenge in healthcare facilities, with implications for morbidity, length of stay, and healthcare costs. This review synthesizes the latest evidence and guidelines on nursing-led strategies to prevent unintentional dislodgement or extraction of invasive and non-invasive medical devices. Emphasis is placed on risk identification, clinical vigilance, patient-centered interventions, and multidisciplinary collaboration to optimize outcomes and minimize complications associated with device management.
The increasing reliance on medical devices such as vascular catheters, feeding tubes, endotracheal tubes, and urinary catheters is integral to contemporary patient care, particularly in critical and acute care settings. Accidental removal of these devices, whether self-induced or iatrogenic, can precipitate adverse events, including infection, hemorrhage, and delayed therapy. Nurses, as the primary caregivers, play a pivotal role in implementing tailored preventive strategies and ensuring device security while maintaining patient comfort and autonomy. This review aims to delineate evidence-based nursing interventions, explore pathophysiological mechanisms underlying device dislodgement, and highlight current recommendations for clinical practice.
Accidental device removal incidence varies by device type and patient population but remains a notable concern across inpatient settings. Studies report that unplanned extubation rates in intensive care units range from 3% to 16%, while the incidence of unintentional removal of central venous catheters and nasogastric tubes may reach 7%–12% in high-risk cohorts. Pediatric, geriatric, and cognitively impaired patients are particularly vulnerable. Device-associated complications contribute to increased morbidity, prolonged hospitalization, escalated resource utilization, and higher healthcare costs, underscoring the necessity for robust preventive strategies.
The mechanisms underpinning accidental device removal are multifactorial. Patient agitation, delirium, pain, and confusion can prompt self-removal attempts. Iatrogenic factors, such as improper fixation, inadequate surveillance, or suboptimal device selection, further elevate risk. Additionally, physiological responses coughing, vomiting, or involuntary movements can mechanically displace devices. Device-related skin breakdown or discomfort may also precipitate removal, highlighting the interplay between clinical, behavioral, and device-specific factors.
Risk stratification is essential for targeted intervention. Key risk factors include: altered mental status (e.g., delirium, dementia), physical agitation, high dependency or sedation levels, suboptimal communication, device discomfort, underlying neurological disorders, and limited nurse-to-patient ratios. Environmental contributors such as unfamiliar surroundings, noise, and inadequate monitoring further exacerbate vulnerability, particularly among pediatric and geriatric populations. Recognition of these factors informs individualized preventative care plans.
Signs of imminent or actual device dislodgement include device migration, leakage at insertion sites, sudden changes in patient vital signs, localized pain or discomfort, visible device manipulation, and unexpected alarms from monitoring systems. Early clinical recognition allows for prompt intervention, minimizing the risk of adverse sequelae such as bleeding, infection, and therapy interruption.
Diagnosis of accidental device removal is primarily clinical, supported by direct observation, device site inspection, and review of monitoring data. Imaging such as chest or abdominal radiographs may be warranted to confirm device position or identify complications (e.g., pneumothorax, misplacement, retained fragments). Documentation and root cause analysis are crucial for quality improvement and future prevention efforts.
Immediate management entails hemostasis, infection prophylaxis, and assessment for potential complications. Device reinsertion should follow strict aseptic protocols and guideline-directed practices. Ongoing care includes enhanced patient monitoring, education, and psychological support to reduce agitation and self-removal risk. Multimodal interventions securement devices, protective dressings, and behavioral strategies (e.g., distraction, frequent orientation) are advocated. Interdisciplinary collaboration is fundamental, involving physicians, pharmacists, and allied health professionals to address underlying causes such as delirium, pain, or unmet care needs.
Recent innovations focus on advanced securement technologies (e.g., subcutaneous anchors, integrated securement dressings) that provide superior fixation and comfort. Sensor-based alarm systems and real-time monitoring platforms aid in early detection of device manipulation. Integration of delirium and agitation prevention protocols incorporating non-pharmacological and pharmacological strategies has demonstrated efficacy in reducing device removal events. Simulation-based staff training and checklist implementation further enhance adherence to best practices.
Current guidelines from critical care and infection prevention societies advocate for a multifaceted approach to device security. Recommendations emphasize regular risk assessments, use of evidence-based securement methods, continuous staff education, and patient/family engagement in care. Early mobilization, delirium prevention, and minimizing device utilization duration are strongly supported. Documentation of each removal event and structured feedback loops facilitate ongoing improvement and accountability.
Preventing accidental device removal is a critical component of patient safety and quality care. Nursing interventions, grounded in risk assessment, vigilant monitoring, and evidence-based securement, are central to mitigating this preventable complication. Continued innovation, education, and adherence to clinical guidelines will further enhance patient outcomes and reduce the burden of device-related adverse events in healthcare settings.
1.
Both men and women who receive the HPV vaccine have a lower risk of developing multiple cancer types.
2.
Potentially Novel Approach for Treating Advanced Colorectal Cancer with KRAS Mutations.
3.
CAR-T cell therapy for cancer causes 'brain fog,' study shows
4.
In Acute Myeloid Leukemia Diagnosed Recently, FLT3 Inhibitor Is Very Effective.
5.
Cancer research in the US is world class. With the government pulling out, its future is uncertain
1.
Environmental Carcinogen Exposure Risk Modeling: Current Evidence and Clinical Implications
2.
Screening for Cancer-Related Neuromuscular Weakness: Clinical Approaches and Evidence-Based Strategies
3.
A Closer Look at White Blood Cells in Urine: Uncovering the Causes and Treatments
4.
The Silent Killer: Uncovering the Causes and Treatments of Hemorrhagic Gastritis
5.
Exploring The Causes and Consequences of Low Transferrin Saturation
1.
International Conference on Oncology, Cardiology and Critical Care Policy
2.
International Conference on Innovations in Critical Care for Oncology and Cardiology
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Cancer Nursing and Hematology Support
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation